Related Experiment Video
Updated: Aug 19, 2026

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
Published on: August 1, 2025
Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer
Xiaodong Sun1, Henry F Frierson, Ceshi Chen
1Winship Cancer Institute, Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Abstract:
Cancer often results from the accumulation of multiple genetic alterations. Although most malignancies are sporadic, only a small number of genes have been shown to undergo frequent mutations in sporadic cancers. The long arm of chromosome 16 is frequently deleted in human cancers, but the target gene for this deletion has not been identified. Here we report that ATBF1, which encodes a transcription factor that negatively regulates AFP and MYB but transactivates CDKN1A, is a good candidate for the 16q22 tumor-suppressor gene. We narrowed the region of deletion at 16q22 to 861 kb containing ATBF1. ATBF1 mRNA was abundant in normal prostates but more scarce in approximately half of prostate cancers tested. In 24 of 66 (36%) cancers examined, we identified 22 unique somatic mutations, many of which impair ATBF1 function. Furthermore, ATBF1 inhibited cell proliferation. Hence, loss of ATBF1 is one mechanism that defines the absence of growth control in prostate cancer.
Insights
The AT-binding factor 1 (ATBF1) gene, located on chromosome 16q22, is frequently altered in prostate cancer. Loss of ATBF1 function contributes to uncontrolled cell growth, identifying it as a potential tumor suppressor.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Cancer development involves accumulating genetic alterations.
- The tumor suppressor gene targeted by 16q22 deletions in human cancers remains unidentified.
- ATBF1 is a transcription factor regulating AFP, MYB, and CDKN1A.
Purpose of the Study:
- To identify the tumor suppressor gene responsible for 16q22 deletions in human cancers.
- To investigate the role of ATBF1 in prostate cancer development.
Main Methods:
- Deletion mapping to narrow down the 16q22 region to 861 kb containing ATBF1.
- Analysis of ATBF1 mRNA levels in normal and cancerous prostate tissues.
- Somatic mutation analysis of the ATBF1 gene in prostate cancer samples.
- Assessment of ATBF1's effect on cell proliferation.
Main Results:
- ATBF1 was identified as a candidate tumor suppressor gene at 16q22.
- ATBF1 mRNA levels were reduced in approximately 50% of prostate cancers.
- 22 unique somatic mutations in ATBF1 were found in 36% of prostate cancers, many impairing its function.
- ATBF1 demonstrated inhibition of cell proliferation.
Conclusions:
- Loss of ATBF1 function is a mechanism contributing to uncontrolled cell proliferation in prostate cancer.
- ATBF1 acts as a tumor suppressor gene at the 16q22 locus.
- These findings highlight the significance of ATBF1 in prostate tumorigenesis.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Transcription Factors
TGF - β Signaling Pathway

